Mega-selling weight-loss & diabetes drug now shown to reduce risk of kidney failure, deaths - ThePrint
theprint.inSubmitted by theprint2911 in health
Semaglutide once a week reduced risk of adverse outcomes in kidney patients by 24 percent, finds study published in The New England Journal of Medicine.